Home > Insider Trading > Filing (0001225208-10-010384)

Filing Details

Accession Number:: 0001225208-10-010384
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-15 13:00:00
Reporting Period:: 2010-04-13

Filing Date:: 2010-04-15
Accepted Time:: 2010-04-15 16:18:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901430	E John Abele	One Boston Scientific Place Natick MA 01760-1537		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-04-13	100,000	$0.00	13,243,721	No	4	J	Direct
Common Stock	Disposition	2010-04-13	25,000	$6.91	5,366,949	No	4	S	Indirect	By LLC
Common Stock	Disposition	2010-04-13	50,000	$6.91	5,316,949	No	4	S	Indirect	By LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	S	Indirect	By LLC
No	4	S	Indirect	By LLC

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Forward Sale Contract (obligation to sell)	Disposition	2010-04-13	100,000	$0.00	100,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-04-13	2010-04-13	No	4	J	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	400,000	Indirect	By Spouse
Common Stock	351,098	Indirect	By Trust

Footnotes

On April 13, 2010, the reporting person settled a prepaid variable forward sale contract entered into on April 13, 2009 with an unaffiliated commercial bank. At the initiation of the contract, the bank paid $645,995.24 to the reporting person. The contract obligated the reporting person to deliver to the bank up to 100,000 shares of the Issuer's common stock depending on market prices at maturity. If the market price per share at maturity was equal to or less than the floor price of $8.77 per share, the reporting person would deliver 100,000 shares to the bank. If the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. The market price per share on April 13, 2010 was less than $8.77. Accordingly, the reporting person transferred to the bank 100,000 shares of the Issuer's common stock.
Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $6.96 to $6.86. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
Common stock held by a limited liability company of which reporting person holds 100% membership interest.
The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $6.96 to $6.84. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
Common stock held by the reporting person's wife. The reporting person disclaims beneficial ownership of these shares.
Common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. The reporting person disclaims beneficial ownership of these shares.